Humana (NYSE:HUM) Price Target Raised to $340.00 at Bank of America

Humana (NYSE:HUM) had its price objective boosted by equities researchers at Bank of America from $267.00 to $340.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the insurance provider’s stock. Bank of America‘s price objective suggests a potential downside of 2.66% from the stock’s current price.

Several other equities analysts also recently weighed in on the company. Sanford C. Bernstein restated an “outperform” rating and issued a $425.00 target price on shares of Humana in a research report on Wednesday. JPMorgan Chase & Co. raised their target price on Humana from $180.00 to $214.00 and gave the company a “neutral” rating in a research report on Friday, May 1st. Wells Fargo & Company lowered Humana from a “cautious” rating to a “reduce” rating in a report on Wednesday, May 20th. UBS Group raised their price objective on Humana from $262.00 to $320.00 and gave the company a “neutral” rating in a report on Friday, May 22nd. Finally, Leerink Partners raised their price objective on Humana from $185.00 to $255.00 and gave the company a “market perform” rating in a report on Thursday, April 30th. Nine research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $279.30.

Humana Price Performance

Shares of NYSE:HUM traded up $21.74 during midday trading on Thursday, reaching $349.28. 995,402 shares of the company’s stock traded hands, compared to its average volume of 1,912,221. Humana has a 1 year low of $163.11 and a 1 year high of $351.76. The company has a market cap of $41.93 billion, a P/E ratio of 37.32, a PEG ratio of 2.33 and a beta of 0.76. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The company has a fifty day simple moving average of $241.36 and a two-hundred day simple moving average of $230.78.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. During the same quarter last year, the firm posted $11.58 EPS. The business’s revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. Equities analysts predict that Humana will post 9 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Humana by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock worth $3,652,890,000 after acquiring an additional 106,030 shares during the period. Capital International Investors raised its holdings in shares of Humana by 113.9% during the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after acquiring an additional 3,097,571 shares during the period. Pzena Investment Management LLC raised its holdings in shares of Humana by 34.3% during the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after acquiring an additional 1,398,774 shares during the period. State Street Corp raised its holdings in shares of Humana by 1.8% during the 4th quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock worth $1,403,877,000 after acquiring an additional 97,211 shares during the period. Finally, Massachusetts Financial Services Co. MA raised its holdings in shares of Humana by 28.9% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock worth $1,151,759,000 after acquiring an additional 1,008,514 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.